Nikolay A. Baykov
Research Subjects
Nikolay A. Baykov has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aleksei G. Martov
Central Clinical Hospital of Civil Aviation”; Medical and Biological University of Innovation and Continuing Education — Burnazyan Federal Medical Biophysical Center of the FMBA of Russia; Medical Scientific and Educational Center — Lomonosov Moscow State University (Lomonosov University)
2 shared publications Aleksandr G. Kochetov
Vishnevsky National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital; BIOTECH University
1 shared publication- D. V. Ergakov
D.D. Pletnev City Clinical Hospital, Moscow Healthcare Department
1 shared publication - D.V. Ergakov Ergakov
Department of Urology and Andrology of A.I. Burnazyan SRC FMBC, FMBA of Russia, Moscow, Russia
1 shared publication - K. A. Asliev
Pletnev City Clinical Hospital
1 shared publication Байков Николай Александрович
ФГБУ «Национальный медицинский исследовательский центр высоких медицинских технологий – Центральный военный клинический госпиталь им. А.А. Вишневского» Минобороны России
1 shared publication
Latest Publications
- Open Access
- 15 July 2023
- Published by Consilium Medicum in Consilium Medicum
- Vol. 25 (7) , 461-466
Application of the UPOINT classification to determine indications for antibacterial therapy of chronic inflammatory process
Background. Patients with chronic prostatitis (CP) represent the majority of urological referral. The most patients, independent of their age, visit attending urologists constantly. Aim. To evaluate the rate of antibiotics prescriptions based on the UPOINTS chronic prostatitis classification and the estimation of its efficacy. Materials and methods. In 2022–2023 there were enrolled 92 CP patients in the Pletnev City Clinical Hospital and Vishnevsky National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital. The age varies from 22 to 46 year (mean 34±8). The diagnosis lifespan was – 11+16.5 mo. The NIH-CPSI score was 23±6.1 (pain 8±5.5, urination – 7±2.4, life quality 8±3.6). The prostate volume was 26±8 cc. The positive Meares-Stamey test was occurred in 38/92 (41%) cases. The positive prostate or sperm culture were found in 18/92 (20%) pts. The positive PCR-tests were obtained in 32/42 (76%) urethral samples, prostate secretes 23/42 (55%) and sperm – 20/42 (48%). Fluorochinilones were prescribed in all 92 (100%) cases, tetracycline (66 patients, 72%) and macrolides – 48 patients, 52%. Results. Sixty eight (74%) pts have passed the follow-up. The total NIH-CSPI score decreased to 15±5.3 (pain – 6±3.6, urination – 5±2.1, life quality 4±2). The average prostate volume was 23±4 cc, at 86% (58) cases were achieved the laboratory tests normalization. The fluorchinolones efficacy was – 29% (17 patients), tetracycline – 41% (24 patients), macrolides – 29% (17 patients). Conclusion. The UPOINT classification use allows optimize the CP management. PCR-tets are the most sensitive in terms of the I-type CP diagnosis. The administration of Doxycycline Express® in the I-type of CP treatment is the most effective (41%) in the comparison to the other antibiotics.
- 15 July 2023
- Published by Consilium Medicum in Consilium Medicum
- Vol. 25 (7) , 461-466
Open AccessApplication of the UPOINT classification to determine indications for antibacterial therapy of chronic inflammatory process
Background. Patients with chronic prostatitis (CP) represent the majority of urological referral. The most patients, independent of their age, visit attending urologists constantly. Aim. To evaluate the rate of antibiotics prescriptions based on the UPOINTS chronic prostatitis classification and the estimation of its efficacy. Materials and methods. In 2022–2023 there were enrolled 92 CP patients in the Pletnev City Clinical Hospital and Vishnevsky National Medical Research Center for High Medical Technologies – Central Military Clinical Hospital. The age varies from 22 to 46 year (mean 34±8). The diagnosis lifespan was – 11+16.5 mo. The NIH-CPSI score was 23±6.1 (pain 8±5.5, urination – 7±2.4, life quality 8±3.6). The prostate volume was 26±8 cc. The positive Meares-Stamey test was occurred in 38/92 (41%) cases. The positive prostate or sperm culture were found in 18/92 (20%) pts. The positive PCR-tests were obtained in 32/42 (76%) urethral samples, prostate secretes 23/42 (55%) and sperm – 20/42 (48%). Fluorochinilones were prescribed in all 92 (100%) cases, tetracycline (66 patients, 72%) and macrolides – 48 patients, 52%. Results. Sixty eight (74%) pts have passed the follow-up. The total NIH-CSPI score decreased to 15±5.3 (pain – 6±3.6, urination – 5±2.1, life quality 4±2). The average prostate volume was 23±4 cc, at 86% (58) cases were achieved the laboratory tests normalization. The fluorchinolones efficacy was – 29% (17 patients), tetracycline – 41% (24 patients), macrolides – 29% (17 patients). Conclusion. The UPOINT classification use allows optimize the CP management. PCR-tets are the most sensitive in terms of the I-type CP diagnosis. The administration of Doxycycline Express® in the I-type of CP treatment is the most effective (41%) in the comparison to the other antibiotics.
- Open Access
- 4 April 2023
- Published by Rostov State Medical University in Urology Herald
- Vol. 11 (1) , 59-69
Ejaculation-sparing enucleation of benign prostate hyperplasia: is it almost feasible?
Introduction. Patients often request maintenance of antegrade ejaculation, and try to find the clinic, surgeon, and treatment to store it. Despite an established technique, the long-term results of ejaculation-sparing operations at a large prostate volume remain unstable. This is not allowed to give patients a guarantee in maintaining this component in their sexual life.Objective. To evaluate the frequency of ejaculation maintenance after laser ejaculatory-sparing prostate enucleation.Materials & methods. Since 2017 ejaculation-sparing laser enucleations have been performed in prostate volume (V pr > 80 cc) in 84 patients. Fifty-four patients (64%) had three lobes benign prostate hyperplasia (BPH) and two lobes — 30 patients (36%). Preoperative voiding parameters were IPSS score — 21.0 ± 2.7, QoL — 4.8 ± 0.6, residual urine volume (V res) — 139 ± 43 mL, Q max — 8.1 ± 2.0 mL. We estimate the result as positive if antegrade ejaculation remained after intervention. If ejaculation volume decreased, then as partially positive and negative — ejaculation was absent postoperatively. We conducted questionnaire and follow-up examination 3 – 6 months after intervention.Results. Thulium-fiber laser enucleations have been performed in all cases without any serious complications. Followup 3 – 6 months after operation showed V pr — 29 ± 4 cc, V res — 19 ± 17 mL, Q max — 19.1 ± 3.1 mL/sec. IPSS score — 8.1 ± 1.9 and QoL — 2.6 ± 0.7. There are the following technical remarks: 1) tissue-sparing in the verumontanum; 2) no or minor mechanical tissue tension during enucleation; 3) avoid additional resection in the bladder neck; 4) refuse total coagulation; 5) no urethral catheter tension after operation; 6) catheter balloon inflow only in the bladder, not in the fossa. Antegrade ejaculation has stored at 17 (20%) patients, partial ejaculation — at 34 (40%) patients, so overall efficacy is 60%. The presence of a median lobe is shown to be negative prognostic factor due to the absence of full antegrade ejaculation in all cases. A partial ejaculation was achieved at 21 patients. Based on the obtained results we have optimized the three-lobe prostate enucleation technique. Four from our initial 7 patients had full storage of ejaculation and 3 — partial.Conclusion. The possibility of BPH laser surgery to store ejaculation function at the request of the patients is modest. The presence of the median lobe makes the full ejaculation-sparing impossible. In cases of two lobes BPH full storage of the ejaculation was at 57% and partial at 43%, respectively. The following evaluation of the described technique is mandatory.
- 4 April 2023
- Published by Rostov State Medical University in Urology Herald
- Vol. 11 (1) , 59-69
Open AccessEjaculation-sparing enucleation of benign prostate hyperplasia: is it almost feasible?
Introduction. Patients often request maintenance of antegrade ejaculation, and try to find the clinic, surgeon, and treatment to store it. Despite an established technique, the long-term results of ejaculation-sparing operations at a large prostate volume remain unstable. This is not allowed to give patients a guarantee in maintaining this component in their sexual life.Objective. To evaluate the frequency of ejaculation maintenance after laser ejaculatory-sparing prostate enucleation.Materials & methods. Since 2017 ejaculation-sparing laser enucleations have been performed in prostate volume (V pr > 80 cc) in 84 patients. Fifty-four patients (64%) had three lobes benign prostate hyperplasia (BPH) and two lobes — 30 patients (36%). Preoperative voiding parameters were IPSS score — 21.0 ± 2.7, QoL — 4.8 ± 0.6, residual urine volume (V res) — 139 ± 43 mL, Q max — 8.1 ± 2.0 mL. We estimate the result as positive if antegrade ejaculation remained after intervention. If ejaculation volume decreased, then as partially positive and negative — ejaculation was absent postoperatively. We conducted questionnaire and follow-up examination 3 – 6 months after intervention.Results. Thulium-fiber laser enucleations have been performed in all cases without any serious complications. Followup 3 – 6 months after operation showed V pr — 29 ± 4 cc, V res — 19 ± 17 mL, Q max — 19.1 ± 3.1 mL/sec. IPSS score — 8.1 ± 1.9 and QoL — 2.6 ± 0.7. There are the following technical remarks: 1) tissue-sparing in the verumontanum; 2) no or minor mechanical tissue tension during enucleation; 3) avoid additional resection in the bladder neck; 4) refuse total coagulation; 5) no urethral catheter tension after operation; 6) catheter balloon inflow only in the bladder, not in the fossa. Antegrade ejaculation has stored at 17 (20%) patients, partial ejaculation — at 34 (40%) patients, so overall efficacy is 60%. The presence of a median lobe is shown to be negative prognostic factor due to the absence of full antegrade ejaculation in all cases. A partial ejaculation was achieved at 21 patients. Based on the obtained results we have optimized the three-lobe prostate enucleation technique. Four from our initial 7 patients had full storage of ejaculation and 3 — partial.Conclusion. The possibility of BPH laser surgery to store ejaculation function at the request of the patients is modest. The presence of the median lobe makes the full ejaculation-sparing impossible. In cases of two lobes BPH full storage of the ejaculation was at 57% and partial at 43%, respectively. The following evaluation of the described technique is mandatory.